CVS
CVS HealthPrevious close
91.72
Change
−2.77 / −2.93%
52-Week Range
69.51 – 110.68
P/E (TTM)
24.4
Forward P/E
13.2
Based on consensus earnings for the next 12 months
Market Cap
$117B
1M
−2.44%
S&P 500 −2.41% over same period
Volume / Avg Volume
7.2M / 5.0M
1.45× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-08-05 | $106B | 2.58 / 1.87 | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-05-06 | $100B | 2.57 / 2.22 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-10 | $402B | 1.09 / 1.00 | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-29 | $103B | 1.60 / 1.38 | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-31 | $98.9B | 1.81 / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-05-01 | $94.6B | 2.25 / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 65 of its 5-year rangeMid-range
5-year range 10.0 – 205.1 · Median 17.7
Last 4 quarters: $0 in buybacks + $3.4B in dividends, 2.91% of market cap combined
P/E (TTM)
24.4
P/B
1.5
P/S
0.3
Dividend Yield
3.49%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.3% on average on the first trading day after, rising 3 times
Most recent −2.93%
Volatility & Correlation
1-year beta 0.17 · Correlation with S&P 500 0.07Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 106.10 | +7.3% | 44.5% | 2.98 | 2.31 |
| FY2026 Q1 | 100.43 | +6.2% | 44.8% | 2.94 | 2.30 |
| FY2025 Q4 | 105.69 | +8.2% | 44.1% | 2.94 | 2.31 |
| FY2025 Q3 | 102.87 | +7.8% | 44.5% | -3.98 | -3.13 |
| FY2025 Q2 | 98.92 | +8.4% | 45.4% | 1.02 | 0.80 |
| FY2025 Q1 | 94.59 | +7.0% | 46.0% | 1.78 | 1.41 |
| FY2024 Q4 | 97.71 | +4.2% | 43.4% | 1.64 | 1.30 |
| FY2024 Q3 | 95.43 | +6.3% | 44.5% | 0.09 | 0.07 |
| FY2024 Q2 | 91.23 | +2.6% | 45.2% | 1.77 | 1.41 |
| FY2024 Q1 | 88.44 | +3.7% | 45.6% | 1.11 | 0.88 |
| FY2023 Q4 | 93.81 | +11.9% | 38.8% | 2.05 | 1.59 |
| FY2023 Q3 | 89.76 | +10.6% | 39.1% | 2.26 | 1.75 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| CVS | 24.4 | +7.3% | 44.5% | −2.44% | Bullish |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |